Showing results (111-120 of 6,708) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|March 25, 2021
Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia ModelSilvia Busquets, Marta Castillejo, Queralt Jové, et al.Oncotargets and Therapy|March 25, 2021
Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMTJian Sun, Weiwei Sheng, Yuteng Ma, et al.Oncotargets and Therapy|July 28, 2011
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatmentsShilpa Gupta, Estrella Carballido, Mayer FishmanOncotargets and Therapy|July 28, 2011
Current therapeutic strategies for invasive and metastatic bladder cancerPrakash Vishnu, Jacob Mathew, Winston W TanOncotargets and Therapy|April 14, 2012
Hedgehog pathway as a drug target: Smoothened inhibitors in developmentTara L Lin, William MatsuiOncotargets and Therapy|June 22, 2011
Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasisBrent S Sorenson, Kaysie L Banton, Lance B Augustin, et al.Oncotargets and Therapy|May 10, 2011
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targetsValentinos Kounnis, Elli Ioachim, Martin Svoboda, et al.Oncotargets and Therapy|December 14, 2011
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancerEva Muñoz-Couselo, José Pérez-García, Javier CortésOncotargets and Therapy|December 14, 2011
Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapiesMasao Kobayakawa, Yasushi KojimaOncotargets and Therapy|March 1, 2012
Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiationNaduparambil K Jacob, James V Cooley, Katsuyuki Shirai, et al.Pageof 671